NO20054032L - Glykolipidderivater, fremgangsmate for fremstilling derav, mellomprodukter for fremstilling derav oq fremgangsmater for fremstilling av mellomproduktene. - Google Patents
Glykolipidderivater, fremgangsmate for fremstilling derav, mellomprodukter for fremstilling derav oq fremgangsmater for fremstilling av mellomproduktene.Info
- Publication number
- NO20054032L NO20054032L NO20054032A NO20054032A NO20054032L NO 20054032 L NO20054032 L NO 20054032L NO 20054032 A NO20054032 A NO 20054032A NO 20054032 A NO20054032 A NO 20054032A NO 20054032 L NO20054032 L NO 20054032L
- Authority
- NO
- Norway
- Prior art keywords
- substituted
- unsubstituted
- preparation
- intermediates
- processes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C247/00—Compounds containing azido groups
- C07C247/02—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton
- C07C247/04—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Crystallography & Structural Chemistry (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003037397 | 2003-02-14 | ||
PCT/JP2004/001566 WO2004072091A1 (fr) | 2003-02-14 | 2004-02-13 | Derives de glycolipide, leur procede de production, intermediaires pour la synthese associee, et procede de production desdits intermediaires |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20054032D0 NO20054032D0 (no) | 2005-08-30 |
NO20054032L true NO20054032L (no) | 2005-11-01 |
Family
ID=32866358
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20054032A NO20054032L (no) | 2003-02-14 | 2005-08-30 | Glykolipidderivater, fremgangsmate for fremstilling derav, mellomprodukter for fremstilling derav oq fremgangsmater for fremstilling av mellomproduktene. |
Country Status (12)
Country | Link |
---|---|
US (2) | US7732583B2 (fr) |
EP (2) | EP2343306B1 (fr) |
JP (2) | JP4742220B2 (fr) |
KR (1) | KR20050105215A (fr) |
CN (2) | CN101165047B (fr) |
AU (1) | AU2004210784A1 (fr) |
BR (1) | BRPI0407501A (fr) |
CA (1) | CA2515396A1 (fr) |
ES (2) | ES2450043T3 (fr) |
HU (1) | HUE037560T2 (fr) |
NO (1) | NO20054032L (fr) |
WO (1) | WO2004072091A1 (fr) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9809654B2 (en) | 2002-09-27 | 2017-11-07 | Vaccinex, Inc. | Targeted CD1d molecules |
JP5226311B2 (ja) * | 2004-08-27 | 2013-07-03 | アルバート アインシュタイン カレッジ オブ メディシン オブ イエシバ ユニバーシティ | 免疫及び自己免疫の調節因子としてのセラミド誘導体 |
US7923013B2 (en) * | 2004-12-28 | 2011-04-12 | The Rockefeller University | Glycolipids and analogues thereof as antigens for NKT cells |
CA2591232C (fr) | 2004-12-28 | 2014-10-21 | The Rockefeller University | Glycolipides et analogues associes utilises en tant qu'antigenes des lymphocytes nkt |
EP1905766A1 (fr) * | 2005-07-01 | 2008-04-02 | Japan as represented by President of National Center of Neurology and Psychiatry | Dérivé glycolipidique et agent thérapeutique comprenant ce dérivé en tant que matière active |
WO2008047174A1 (fr) * | 2006-10-18 | 2008-04-24 | Centre National De La Recherche Scientifique | Analogues de l'alpha-galactocéramide, leurs procédés de fabrication, composés intermédiaires utiles dans ces procédés, et compositions pharmaceutiques les contenant |
JP5357782B2 (ja) | 2007-02-21 | 2013-12-04 | バクシネックス インコーポレーティッド | 抗原負荷CD1d分子によるNKT細胞活性の調節 |
JP2012514476A (ja) * | 2009-01-08 | 2012-06-28 | アルバート アインシュタイン カレッジ オブ メディシン オブ イェシバ ユニバーシティ,ア ディビジョン オブ イェシバ ユニバーシティ | 細胞壁結合セラミド様糖脂質による細菌ワクチンおよびその使用 |
CN101775051B (zh) * | 2010-01-07 | 2013-03-27 | 北京大学 | 一种区域选择性脱除糖o-苄基保护基的方法 |
US10632740B2 (en) | 2010-04-23 | 2020-04-28 | Landa Corporation Ltd. | Digital printing process |
US10190012B2 (en) | 2012-03-05 | 2019-01-29 | Landa Corporation Ltd. | Treatment of release layer and inkjet ink formulations |
US10642198B2 (en) | 2012-03-05 | 2020-05-05 | Landa Corporation Ltd. | Intermediate transfer members for use with indirect printing systems and protonatable intermediate transfer members for use with indirect printing systems |
US9381736B2 (en) | 2012-03-05 | 2016-07-05 | Landa Corporation Ltd. | Digital printing process |
US9643403B2 (en) | 2012-03-05 | 2017-05-09 | Landa Corporation Ltd. | Printing system |
US9498946B2 (en) | 2012-03-05 | 2016-11-22 | Landa Corporation Ltd. | Apparatus and method for control or monitoring of a printing system |
US9902147B2 (en) | 2012-03-05 | 2018-02-27 | Landa Corporation Ltd. | Digital printing system |
CA2866204C (fr) | 2012-03-05 | 2020-04-14 | Landa Corporation Ltd. | Structures de films d'encre |
CN104271687B (zh) | 2012-03-05 | 2016-11-02 | 兰达公司 | 油墨膜构造 |
US9643400B2 (en) | 2012-03-05 | 2017-05-09 | Landa Corporation Ltd. | Treatment of release layer |
US10434761B2 (en) | 2012-03-05 | 2019-10-08 | Landa Corporation Ltd. | Digital printing process |
CN104284850B (zh) | 2012-03-15 | 2018-09-11 | 兰达公司 | 打印系统的环形柔性皮带 |
US9371352B2 (en) | 2013-02-08 | 2016-06-21 | Vaccinex, Inc. | Modified glycolipids and methods of making and using the same |
JP6487854B2 (ja) | 2013-02-08 | 2019-03-20 | ヴァクシネックス, インコーポレイテッド | 修飾された糖脂質並びにその製造および使用方法 |
GB201401173D0 (en) | 2013-09-11 | 2014-03-12 | Landa Corp Ltd | Ink formulations and film constructions thereof |
US9782993B2 (en) | 2013-09-11 | 2017-10-10 | Landa Corporation Ltd. | Release layer treatment formulations |
GB2536489B (en) | 2015-03-20 | 2018-08-29 | Landa Corporation Ltd | Indirect printing system |
GB2537813A (en) | 2015-04-14 | 2016-11-02 | Landa Corp Ltd | Apparatus for threading an intermediate transfer member of a printing system |
DE112017002714T5 (de) | 2016-05-30 | 2019-02-28 | Landa Corporation Ltd. | Digitales Druckverfahren |
GB201609463D0 (en) | 2016-05-30 | 2016-07-13 | Landa Labs 2012 Ltd | Method of manufacturing a multi-layer article |
JP7206268B2 (ja) | 2017-10-19 | 2023-01-17 | ランダ コーポレイション リミテッド | 印刷システム用の無端可撓性ベルト |
JP7225230B2 (ja) | 2017-11-19 | 2023-02-20 | ランダ コーポレイション リミテッド | デジタル印刷システム |
WO2019102297A1 (fr) | 2017-11-27 | 2019-05-31 | Landa Corporation Ltd. | Système d'impression numérique |
US11707943B2 (en) | 2017-12-06 | 2023-07-25 | Landa Corporation Ltd. | Method and apparatus for digital printing |
WO2019111223A1 (fr) | 2017-12-07 | 2019-06-13 | Landa Corporation Ltd. | Système et procédé d'impression numérique |
CN112399918B (zh) | 2018-06-26 | 2023-01-31 | 兰达公司 | 数字印刷系统的中间传输构件 |
US10994528B1 (en) | 2018-08-02 | 2021-05-04 | Landa Corporation Ltd. | Digital printing system with flexible intermediate transfer member |
WO2020075012A1 (fr) | 2018-10-08 | 2020-04-16 | Landa Corporation Ltd. | Moyens de réduction de frottement pour systèmes d'impression et procédé |
CN113272144B (zh) | 2018-12-24 | 2023-04-04 | 兰达公司 | 数字印刷系统和方法 |
EP4066064A4 (fr) | 2019-11-25 | 2024-01-10 | Landa Corp Ltd | Séchage d'encre en impression numérique avec un rayonnement infrarouge absorbé par des particules incorporées à l'intérieur d'un itm |
US11321028B2 (en) | 2019-12-11 | 2022-05-03 | Landa Corporation Ltd. | Correcting registration errors in digital printing |
JPWO2022102557A1 (fr) * | 2020-11-12 | 2022-05-19 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6072960A (ja) * | 1983-09-30 | 1985-04-25 | Sumitomo Chem Co Ltd | モノアゾ化合物およびそれを用いて染色または捺染する方法 |
JPH0559081A (ja) * | 1991-08-29 | 1993-03-09 | Kirin Brewery Co Ltd | 新規スフインゴ糖脂質、その製造法および使用 |
US5936076A (en) * | 1991-08-29 | 1999-08-10 | Kirin Beer Kabushiki Kaisha | αgalactosylceramide derivatives |
ATE191916T1 (de) * | 1992-10-22 | 2000-05-15 | Kirin Brewery | Neues sphingolglycolipid und verwendung davon |
JP2002226377A (ja) * | 1996-10-14 | 2002-08-14 | Kirin Brewery Co Ltd | 配糖体含有末梢血幹細胞増加剤 |
DE69828603T2 (de) * | 1997-04-10 | 2005-12-29 | Kirin Beer K.K. | Verwendung von a-Glycosylceramiden zur Herstellung eines therapeutischen Mittels zur Behandlung von Autoimmunkrankheiten |
HU229345B1 (en) * | 2001-08-16 | 2013-11-28 | Japan Government | Novel glycolipid and remedial agent for autoimmune disease containing the same as active ingredient |
-
2004
- 2004-02-13 ES ES04710993.9T patent/ES2450043T3/es not_active Expired - Lifetime
- 2004-02-13 EP EP11160814.7A patent/EP2343306B1/fr not_active Expired - Lifetime
- 2004-02-13 HU HUE11160814A patent/HUE037560T2/hu unknown
- 2004-02-13 WO PCT/JP2004/001566 patent/WO2004072091A1/fr active Application Filing
- 2004-02-13 BR BRPI0407501-3A patent/BRPI0407501A/pt not_active IP Right Cessation
- 2004-02-13 KR KR1020057014984A patent/KR20050105215A/ko not_active Application Discontinuation
- 2004-02-13 AU AU2004210784A patent/AU2004210784A1/en not_active Abandoned
- 2004-02-13 CN CN2007101544258A patent/CN101165047B/zh not_active Expired - Lifetime
- 2004-02-13 ES ES11160814.7T patent/ES2676345T3/es not_active Expired - Lifetime
- 2004-02-13 CN CNB200480004216XA patent/CN100537585C/zh not_active Expired - Lifetime
- 2004-02-13 JP JP2005505007A patent/JP4742220B2/ja not_active Expired - Lifetime
- 2004-02-13 EP EP04710993.9A patent/EP1619199B1/fr not_active Expired - Lifetime
- 2004-02-13 CA CA002515396A patent/CA2515396A1/fr not_active Abandoned
- 2004-02-13 US US10/545,421 patent/US7732583B2/en active Active
-
2005
- 2005-08-30 NO NO20054032A patent/NO20054032L/no not_active Application Discontinuation
-
2010
- 2010-04-15 US US12/760,793 patent/US8034908B2/en not_active Expired - Fee Related
- 2010-10-12 JP JP2010229896A patent/JP5246448B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU2004210784A1 (en) | 2004-08-26 |
WO2004072091B1 (fr) | 2004-11-11 |
CN101165047B (zh) | 2010-10-20 |
CN100537585C (zh) | 2009-09-09 |
JP2011063593A (ja) | 2011-03-31 |
US7732583B2 (en) | 2010-06-08 |
NO20054032D0 (no) | 2005-08-30 |
ES2676345T3 (es) | 2018-07-18 |
CN101165047A (zh) | 2008-04-23 |
BRPI0407501A (pt) | 2006-02-14 |
JP4742220B2 (ja) | 2011-08-10 |
ES2450043T3 (es) | 2014-03-21 |
US20100210828A1 (en) | 2010-08-19 |
EP2343306A1 (fr) | 2011-07-13 |
EP2343306B1 (fr) | 2018-04-04 |
HUE037560T2 (hu) | 2018-09-28 |
US20060074235A1 (en) | 2006-04-06 |
EP1619199A1 (fr) | 2006-01-25 |
WO2004072091A1 (fr) | 2004-08-26 |
CN1768072A (zh) | 2006-05-03 |
JPWO2004072091A1 (ja) | 2006-06-01 |
EP1619199B1 (fr) | 2013-12-18 |
CA2515396A1 (fr) | 2004-08-26 |
KR20050105215A (ko) | 2005-11-03 |
EP1619199A4 (fr) | 2009-12-16 |
JP5246448B2 (ja) | 2013-07-24 |
US8034908B2 (en) | 2011-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20054032L (no) | Glykolipidderivater, fremgangsmate for fremstilling derav, mellomprodukter for fremstilling derav oq fremgangsmater for fremstilling av mellomproduktene. | |
ES2188016T3 (es) | Derivaqdo de benzamidoxima, productos intermedios y procedimiento para su obtencion y su empleo como fungicidas. | |
CO6300867A2 (es) | Derivados polisustituidos de 2 -heteroaril-6-fenil-imidazo[1,2-a]piridinas su preparacion y su aplicacion en terapeutica | |
BG108174A (en) | 5-phenylpyrimidines, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi | |
DE60301345D1 (de) | Stabilisierte askorbinsäurederivate | |
HUP0300080A2 (hu) | Új malonsavszármazékok, eljárás előállításukra, ezek alkalmazása Xa faktor inhibitorként és ezeket tartalmazó gyógyszerkészítmények | |
NO20085140L (no) | Nye indazolderivater som har spiro ringstruktur i sidekjede | |
CY1111528T1 (el) | 1-αζα-δικυκλο [3.3.1] εννεανια | |
DK1008592T3 (da) | Cykliske amidderivater, som inhiberer cathepsin K | |
EA200200098A1 (ru) | Ароматические сложные эфиры для маркировки или мечения нефтепродуктов | |
EP1634874A4 (fr) | Derive d'imidazolidine | |
BRPI0408160B1 (pt) | Processo para o preparo de ésteres do ácido nicotínico substituído e intermediários de enamina para uso nesse processo | |
CR7249A (es) | Derivados de diamina, proceso para producir los derivados de diamina, y funguicidas que contienen los derivados de diamina como ingrediente activo | |
NO20062083L (no) | Nye fenylpyridylpiperazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
NO20055167L (no) | Nye benzotiadiazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
NO20013643D0 (no) | Fremgangsmåte for fremstilling av en optisk aktiv alkohol | |
NO20082698L (no) | Nye derivater, deres salter og antisoppmidler inneholdende disse | |
NO20091779L (no) | Nye indolforbindelser en prosess for deres fremstilling og farmasoytiske sammensetninger som inneholder dem | |
CY1105158T1 (el) | Εκδοχα πυριδοϊνδολονης που φερει υποκαταστατη στο -3 μια ετepοκυκλικη ομαδα, η παρασκευη τους και η εφαρμογη τους στη θepαπευτικη | |
NO20055844D0 (no) | Nye benzotiazin og benzotiadiazinforbindelsep fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
NO20062100L (no) | Nye fenylpyridylpiperazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
DE60313798D1 (en) | Halothienoylcyclopropan-1-carbonsaeure-derivate | |
AR058839A1 (es) | Derivados de piperidina, utiles para el tratamiento de enfermedades proliferativas | |
NO20045540L (no) | Nye 3-(4-okso-4H-kromen-2-yl)-(1H)-kinolin-4-on-forbindelser, en fremgangsmate for deres fremstilling og farmasoytisk sammensetninger inneholdende dem | |
DE69001852T2 (de) | Herstellung von derivaten der glutarsaeure. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |